Virios Therapeutics, Inc. (VIRI)
USD 0.16
(12.4%)
USD 0.16
(12.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.87 Million | -11.46 Million | -15.68 Million | -3.89 Million | -2.09 Million | -1.19 Million |
| Net Income | -5.29 Million | -12.24 Million | -15.96 Million | -10.34 Million | -2.47 Million | -2.11 Million |
| Depreciation & Amortization | - | - | - | 53.98 Thousand | - | - |
| Deferred income taxes | - | - | - | -53.98 Thousand | - | - |
| Stock-based compensation | 619.97 Thousand | 582.65 Thousand | 322.88 Thousand | 7.42 Million | - | - |
| Change in working capital | -194.44 Thousand | 197.37 Thousand | -52.19 Thousand | -974.06 Thousand | 316.47 Thousand | 869.13 Thousand |
| Other non-cash items | 1.08 Million | 363.35 Thousand | 52.87 Thousand | -4258.00 | 65 Thousand | 48.5 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.15 Million | 4.49 Million | -97.6 Thousand | 33.38 Million | 2.37 Million | 1.15 Million |
| Debt repayment | - | - | - | -1.93 Million | -2.37 Million | - |
| Dividends payments | - | - | - | -75 Thousand | - | - |
| Common Stock Repurchased | - | - | -295.16 Thousand | -1.85 Million | - | - |
| Common Stock Issuance | 1.15 Million | 4.49 Million | -97.6 Thousand | 31.34 Million | - | 1.22 Million |
| Other Financing Activities | 1.15 Million | 4490.61 | 295.16 Thousand | 5.89 Million | 4.74 Million | 1.15 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -461.25 Thousand | 219.3 Thousand | 270 Thousand | 51.56 Thousand | -89.82 Thousand | 65.63 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 266.8 Thousand | -21.92 Thousand | -322.19 Thousand | -1.02 Million | 406.3 Thousand | 803.49 Thousand |
| Cash at beginning of period | 7.03 Million | 14 Million | 29.79 Million | 309.38 Thousand | 30.02 Thousand | 75.51 Thousand |
| Cash at end of period | 3.31 Million | 7.03 Million | 14 Million | 29.79 Million | 309.38 Thousand | 30.02 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3.71 Million | -6.97 Million | -15.78 Million | 29.48 Million | 279.35 Thousand | -45.48 Thousand |
| Free Cash Flow | -4.87 Million | -11.46 Million | -15.68 Million | -3.89 Million | -2.09 Million | -1.19 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.04 Million | -1.29 Million | -5.29 Million | -1.1 Million | -1.23 Million | -1.44 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 148.94 Thousand | 138.96 Thousand | 619.97 Thousand | 148.3 Thousand | 148.3 Thousand | 161.66 Thousand |
| Change in working capital | 89.13 Thousand | 214.95 Thousand | -194.44 Thousand | -514.3 Thousand | 126.31 Thousand | 536.82 Thousand |
| Other non-cash items | 198.17 Thousand | 54.12 Thousand | 1.08 Million | 241.76 Thousand | 157.24 Thousand | 82.45 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.45 Million | - | 1.15 Million | 2.31 Million | 1.15 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.45 Million | - | 1.15 Million | 1.15 Million | 1.15 Million | - |
| Other Financing Activities | - | - | 1.15 Million | -1.15 Million | 1156.44 | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -49.22 Thousand | 84.84 Thousand | -461.25 Thousand | -93.45 Thousand | -8936.00 | 79.21 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 138.36 Thousand | 130.1 Thousand | 266.8 Thousand | -420.84 Thousand | 135.25 Thousand | 457.61 Thousand |
| Cash at beginning of period | 2.37 Million | 3.31 Million | 7.03 Million | 4.78 Million | 4.59 Million | 5.33 Million |
| Cash at end of period | 3.02 Million | 2.37 Million | 3.31 Million | 3.31 Million | 4.78 Million | 4.59 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 640.65 Thousand | -937.41 Thousand | -3.71 Million | -1.46 Million | 195.98 Thousand | -742.41 Thousand |
| Free Cash Flow | -811.74 Thousand | -937.41 Thousand | -4.87 Million | -1.46 Million | -960.45 Thousand | -742.41 Thousand |
DODLA
SAF
SCVPF
MDXH
KAST
TXO